GFVRX
Price
$15.15
Change
+$0.12 (+0.80%)
Updated
Apr 2 closing price
Net Assets
58.66M
VFINX
Price
$523.30
Change
+$3.51 (+0.68%)
Updated
Apr 2 closing price
Net Assets
1.4T
Ad is loading...

GFVRX vs VFINX

Header iconGFVRX vs VFINX Comparison
Open Charts GFVRX vs VFINXBanner chart's image
Goldman Sachs Focused Value R
Price$15.15
Change+$0.12 (+0.80%)
VolumeN/A
Net Assets58.66M
Vanguard 500 Index Investor
Price$523.30
Change+$3.51 (+0.68%)
VolumeN/A
Net Assets1.4T
GFVRX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFVRX vs. VFINX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFVRX is a StrongBuy and VFINX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.4T vs. GFVRX (58.7M). VFINX pays higher dividends than GFVRX: VFINX (1.24) vs GFVRX (0.00). GFVRX was incepted earlier than VFINX: GFVRX (10 years) vs VFINX (49 years). GFVRX (1.93) is less costly to investors than VFINX (0.14). GFVRX is a more actively managed with annual turnover of: 85.00 vs. VFINX (2.00). GFVRX (0) and VFINX (0) have matching initial minimum investment requirements. VFINX annual gain was more profitable for investors over the last year : 7.06 vs. GFVRX (-1.83). VFINX return over 5 years is better than : 122.20 vs. GFVRX (81.21).
GFVRXVFINXGFVRX / VFINX
Total Expense Ratio1.260.14900%
Annual Report Gross Expense Ratio1.930.141,379%
Fund Existence10 years49 years-
Gain YTD-2.276-4.59750%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets58.7M1.4T0%
Annual Yield % from dividends0.001.24-
Returns for 1 year-1.837.06-26%
Returns for 3 years5.3423.5323%
Returns for 5 years81.21122.2066%
Returns for 10 yearsN/A171.96-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TREE52.762.49
+4.95%
LendingTree
XTNT0.47N/A
+0.02%
Xtant Medical Holdings
APTO3.15N/A
N/A
Aptose Biosciences. Inc.
TEVA15.29-0.08
-0.52%
Teva Pharmaceutical Industries Limited
INDV9.38-0.15
-1.57%
Indivior PLC